- Technical Note
- Open Access
Rapid screening of innate immune gene expression in zebrafish using reverse transcription - multiplex ligation-dependent probe amplification
© Meijer et al; licensee BioMed Central Ltd. 2011
- Received: 15 March 2011
- Accepted: 15 June 2011
- Published: 15 June 2011
With the zebrafish increasingly being used in immunology and infectious disease research, there is a need for efficient molecular tools to evaluate immune gene expression in this model species. RT-MLPA (reverse transcription - multiplex ligation-dependent probe amplification) provides a sensitive and reproducible method, in which fluorescently labelled amplification products of unique lengths are produced for a defined set of target transcripts. The method employs oligonucleotide probes that anneal to adjacent sites on a target sequence and are then joined by a heat-stable ligase. Subsequently, multiplex PCR with universal primers gives rise to amplicons that can be analyzed with standard sequencing equipment and relative quantification software. Allowing the simultaneous quantification of around 40 selected markers in a one-tube assay, RT-MLPA is highly useful for high-throughput screening applications.
We employed a dual-colour RT-MLPA probe design for chemical synthesis of probe pairs for 34 genes involved in Toll-like receptor signalling, transcriptional activation of the immune response, cytokine and chemokine production, and antimicrobial defence. In addition, six probe pairs were included for reference genes unaffected by infections in zebrafish. First, we established assay conditions for adult zebrafish infected with different strains of Mycobacterium marinum causing acute and chronic disease. Addition of competitor oligonucleotides was required to achieve peak heights in a similar range for genes with different expression levels. For subsequent analysis of embryonic samples it was necessary to adjust the amounts of competitor oligonucleotides, as the expression levels of several genes differed to a large extent between adult and embryonic tissues. Assay conditions established for one-day-old Salmonella typhimurium-infected embryos could be transferred without further adjustment to five-day-old M. marinum-infected larvae. RT-MLPA results were compared with results of previous transcriptome analyses and with real-time PCR data, demonstrating a good correlation between all expression analysis methods.
The RT-MLPA assay developed in this study provides a rapid, cheap, and robust analysis tool for simultaneous quantification of a set of 34 innate immune response genes. With adjustment of conditions, the assay is suitable for infection studies in both adult and embryonic zebrafish. Application of RT-MLPA will facilitate high-throughput screening of immune responses in the zebrafish model.
- Zebrafish Embryo
- Probe Pair
- Adult Zebrafish
- Immune Response Gene
- Mycobacterium Marinum
The use of zebrafish models in immunological and infectious disease research has rapidly expanded over the recent years [1, 2]. Important advantages of zebrafish include its amenability to large-scale forward and reverse genetic screening and small molecule library screening [3, 4]. The recent development of a robotic system for bacterial infection of zebrafish embryos will facilitate antimicrobial drug screening in this model at high-throughput level . The availability of robust molecular tools for the rapid evaluation of immune responses is a highly desired addition to zebrafish-based screening approaches.
Multiplex Ligation-dependent Probe Amplification (MLPA) is a high resolution method to establish the copy number of around 40 nucleic acid sequences in a one-tube reaction [6, 7]. The technique was initially developed to determine copy number variation in genomic DNA, but has also been adapted for quantification of mRNA transcript levels . Since its introduction in 2002, MLPA has rapidly become accepted in genetic diagnostic laboratories, where it is used for the detection of disease-associated polymorphisms, deletions, duplications and rearrangements in genomic DNA . Reasons for the rapid adoption of MLPA in diagnostics are the relative simplicity, low costs (ca. 10 euro per reaction), high-throughput capacity, sensitivity, accuracy and robustness of the technique. The use of reverse-transcriptase-MLPA (RT-MLPA) for mRNA expression profiling is less common but has proven useful for example in human immunology and cancer research [9, 10]. In contrast to approximately 250 MLPA kits available for DNA analysis, only three RT-MLPA kits (including a human inflammation probe set, a human apoptosis probe set, and a mouse inflammation probe set) are commercially available (MRC Holland, http://www.mlpa.com). While the application of existing RT-MLPA tests is fast and simple, the development of new tests for detection of other sets of mRNAs is a significant investment.
Probes used in MLPA usually range between 80 to 400 nucleotides in length. Accurate chemical synthesis of MLPA probes is possible up to a length of approximately 180 nucleotides, while M13 cloning (using SALSA vectors, MRC Holland, http://www.mlpa.com) is used to produce probes up to 400 nucleotides in length [6, 7, 11]. To bypass the laborious M13 cloning procedures, a dual-colour approach has been applied . In this approach, two universal primer pairs are used that give similar amplification efficiencies but are labelled with different fluorophores, thereby increasing the maximum possible number of synthetic probe pairs in a single MLPA assay.
Following probe design, a second time-consuming step in development of an RT-MLPA assay is optimization of the assay conditions by addition of competitor oligonucleotides (probes without universal primer sequences). Competitor oligonucleotides need to be used to titrate down the signals of genes with higher expression levels than others, such that all amplicons will produce peak heights in a similar range . Titration conditions may need to be adjusted separately for different sample types, for example for different tissues or for samples from experimental manipulations that lead to large differences in gene expression. Therefore, RT-MLPA is most useful for high-throughput applications that involve repetitive analysis of a targeted transcript set in similar biological samples.
Here we describe the development of a first RT-MLPA assay for application in zebrafish models. The probe set targets 34 genes with functions in the innate immune system and contains 6 probe pairs for reference genes that are not affected under infection conditions. We show that a dual-colour approach previously developed for MLPA  can also be adopted for RT-MLPA, allowing us to combine 41 synthetic probe pairs in a single assay. We tested the method using samples from Mycobacterium marinum and Salmonella typhimurium infection experiments and established assay conditions for analysis of both adult and embryonic tissues. RT-MLPA results correlated well with results from previous transcriptomics studies and with results from real-time PCR analysis.
MLPA probe and RT-primer design
MLPA probes and RT-primers were designed for target mRNAs of 34 immune response genes and three reference genes (Additional file 1). For each target a pair of probes was designed, binding adjacently to each other on the target sequence, with the resulting ligation site located maximally 7 nucleotides from an exon-exon boundary. In addition, a control probe pair, designed on an intron sequence of one of the targets (cxcr3.2), was included in the set to check for the interference of genomic DNA in the MLPA run. The probe oligos were designed following the guidelines described in the manual "Designing synthetic MLPA probes" (http://www.mlpa.com, MRC Holland, Amsterdam, The Netherlands). All probe pairs contain the same universal binding site for the reverse PCR primer on the right probe oligo (RPO). The left probe oligo (LPO) for approximately half of the immune response genes harbours a sequence corresponding with forward PCR primer 1 labelled with FAM, while the remaining LPOs harbour a different sequence corresponding with forward PCR primer 2 labelled with Texas Red (TR). Two different probe pairs were designed for each of the three reference genes, one for amplification with FAM-labelled primer 1 and one for amplification with TR-labelled primer 2, thus resulting in a total of six RT-MLPA reference sequences. The probe pairs were designed such that the fragments resulting from PCR amplification are spaced by a minimum of three nucleotides in a range from 91-178 base pairs. Additionally, competitor oligonucleotides were created, consisting of the left probe oligo hybridization sequence (LHS), but lacking the universal primer sequence. A synthetic control DNA template was generated for each target and used to test the probe pairs for efficiency in setting up the RT-MLPA assay and as a positive control during runs. RT-Primers, reverse complement to the strand corresponding to the probe sequence, were designed for all target mRNAs, and were positioned immediately adjacent to the actual MLPA probe with no more than 15 nucleotides between the last nucleotide of the primer and the first nucleotide of the probe sequence, and with a maximum overlap of 7 nucleotides. The RT primers all have a Tm in the range of 55-65 °C and a GC content between 35 and 60%.
RT-MLPA reactions were performed using SALSA® MLPA® Reagents kit EK1-RT (MRC-Holland, Amsterdam, The Netherlands) according to the manufacturer's instructions for RT-MLPA reactions (version 10, 18-09-2008). All reaction steps were performed in a thermocycler with heated lid (105°C) using 0.2 ml thin-walled PCR tubes. RPOs were treated with T4 polynucleotide kinase (New England Biolabs) before use to establish 5' phosphorylation. A mix of RT-primers and dNTPs was prepared containing 1 pmol/μl of the RT primer for each target transcript and 2.5 mM of dNTPs. The RT primer/dNTP mix (1 μl) was added to the RNA sample (100 ng total RNA in 2.5 μl) and SALSA RT buffer (1 μl) at 4°C. This mixture was subsequently heated for 1 min to 80°C and incubated for 5 min at 45°C. Subsequently, the temperature was cooled down to 37°C, 30 units of M-MLV Reverse Transcriptase in SALSA dilution buffer (1.5 μl) were added, and the RT reaction was performed for 15 min at 37°C. The RT enzyme was then inactivated by heating to 98°C for 2 min and the mixture was cooled down to 25°C. A probe mix containing all probe oligos was prepared containing 2 fmol/μl of each oligo and, if necessary, competitor oligos were added to the required ratio (Additional file 2). The probe mix (1.5 μl) and MLPA buffer (1.5 μl) were added to the RT reaction, and after heating for 1 min at 95°C, the mixture was incubated for 16 h at 60°C to let the LPO and RPO probes hybridize to their respective targets. Subsequently, the mixture was cooled down to 54°C, 32 μl of Ligase-65 mix was added, and ligation of the LPO and RPO probes was performed by incubating for 15 min at 54°C. The ligase enzyme was inactivated by heating to 98°C for 2 min and the mixture was cooled down to 4°C. Next, 10 μl of the ligation reaction was mixed with 4 μl of SALSA PCR buffer and 26 μl water. When the tubes were in the thermal cycler at 60°C, 10 μl of polymerase mix was added containing 2 μl of PCR primer mix (10 pmol/μl of each forward primer and 20 pmol/μl of the reverse primer), 2 μl SALSA Enzyme Dilution Buffer, 5.5 μl water, and 0.5 μl SALSA Polymerase. The PCR reaction was carried out with slight modifications to the manufacturer's protocol to provide higher selectivity of the PCR primers. To this end the amplification temperature was increased to 65°C, and the number of cycles was increased to 38, resulting in the following cycling conditions: 30 s at 95°C; 30 s at 65°C; 1 min at 72°C. PCR cycling was ended with 20 min incubation at 72°C, after which the reaction was cooled down to 4°C. After PCR, the resulting DNA fragments were treated for 10 min at 37°C with 5 μl of Polymerase I Large Klenow fragment (Promega Corp., Madison, WI, USA) diluted in a 2.5 mM dNTP mix to correct for strand overhang. Next, the fragments were column-purified with the ZR DNA Sequencing Clean-up Kit™ (Zymo Research Corporation, Orange, CA, USA), according to the manufacturer's instructions, to prevent for dye-blobs in capillary fragment analysis. After PCR purification, 0.7 μl of sample was mixed with 0.3 μl of GS500-LIZ size standard and fragment analysis was performed on a ABI 3100 sequencer in GeneScan mode. Data were analyzed using GeneMarker® software, version 1.7 (SoftGenetics, LLC. State College, PA, USA). Raw data were imported with the Analysis Type set on 'Fragment (Animal) Analysis' and the following default settings for the Data Process Options: Raw Data Analysis: auto range, smooth, peak saturation, baseline subtraction, pull-up correction, spike removal; Size call: Local Southern; Allele Call: auto range 60-600 with peak detection threshold settings at: intensity > 100, percentage >5, local region > 25%, max call intensity 30000; Stutter peak filter %: left 90, right 40; Plus-A filter. Data were scaled using the GS500-LIZ size standard and peaks of target transcripts were assigned using a template with the fragment sizes of the RT-MLPA amplification products. A table containing the heights of each assigned peak scored in arbitrary units was exported and further analysed in Microsoft Excel. For normalization of the data, the peak heights of the target transcripts were divided by the average peak heights of the reference genes included in the same dye group. Based on parallel runs of the synthetic DNA control template described above there was no need to correct for possible signal sloping. Fold change values were calculated by dividing the normalized peak values of a treatment sample by the normalized peak values of the control sample.
From 1 μg of total RNA cDNA was synthesized using the I-Script cDNA synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA). For real-time PCR assays SYBR Green Universal PCR Mastermix 2x (Applied Biosystems, Foster City, CA, USA) was used. PCR primers were designed with Primer Express Software version 1.7 (Applied Biosystems, Foster City, CA, USA). For 33 of the 40 RT-MLPA target transcripts, including all six reference sequences, real-time PCR primer sets were developed, covering the hybridization sequence of each RT-MLPA target (Additional file 1). Each real-time PCR reaction contained 12,5 μl 2X PCR Mastermix, forward and reverse primer in a final concentration of 300nM, 1 μl of cDNA template and the volume adjusted to 25 μl with ddH2O. The reactions were run on an ABI PRISM™ 7500 Sequence Detection System (Applied Biosystems). The solution was subjected to a protocol of subsequently 95 °C for 10 minutes, followed by 40 cycles of 15 s at 95 °C and 1 min. at 60 °C. All reactions were performed in duplicate. Relative quantification was performed according to Vandesompele et al.  using three reference genes (coding for tyrosine 3-monooxygenase activation protein (NM_201484), NADH dehydrogenase (AC024175), and 16S ribosomal RNA (CK739347) that were selected from the GeNorm Zebrafish reference kit (PrimerDesign Ltd, Southampton, UK) for normalization.
Total RNA samples from zebrafish adults infected with M. marinum E11 and Mma20 strains and PBS-injected control fish were identical to those used in a previous microarray study . Three biological replicates of infected fish and controls were used for RT-MLPA analysis, similar as in the previous microarray study. Zebrafish embryos at 28 hours post fertilization (hpf) were injected into the caudal vein with approximately 200 colony forming units (CFU) of S. typhimurium infection or injected with PBS as a control. Total RNA was isolated from pools of 15-20 embryos per treatment group at 8 hours post infection (hpi) and subjected to microarray analysis as previously described . Samples were analyzed from three independent S. typhimurium infection experiments. Zebrafish embryos at 48 hpf were injected into the yolk sac with approximately 2000 CFU of M. marinum E11 bacteria in PVP carrier solution or with carrier solution alone as a control . Total RNA was isolated from pools of 15-20 embryos at 3 days post infection (dpi).
Development of an RT-MLPA probe set for the zebrafish innate immune response
Target genes of the zebrafish immune response RT-MLPA assay
Entrez Gene ID
Immune response genes
chemokine ccl-c24a (si:dkey-150o13.1, ccl20)
transcribed locus, weakly similar to NP_001108573.1 chemokine CCL-Cub
chemokine ccl-c5a (si:ch211-89f7.4)
cxc chemokine 46
chemokine cxcl-c1c (si:ch73-6k14.1)
chemokine (C-X-C motif), receptor 3.2
chemokine (C-X-C motif), receptor 4b
FK506 binding protein 5
v-fos FBJ murine osteosarcoma viral oncogene homolog
interferon phi 1
interleukin 1, beta
v-jun sarcoma virus 17 oncogene homolog (c-Jun)
jun B proto-oncogene
matrix metalloproteinase 9
myeloid differentiation primary response gene (88)
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100
v-rel reticuloendotheliosis viral oncogene homolog
v-rel reticuloendotheliosis viral oncogene homolog A
sterile alpha and TIR motif containing 1
spleen focus forming virus (SFFV) proviral integration oncogene spi1 (pu.1)
toll-like receptor adaptor molecule 1 (ticam1, trif)
toll-interleukin 1 receptor (TIR) domain containing adaptor protein (tirap, mal)
toll-like receptor 1
toll-like receptor 4b, duplicate b
toll-like receptor 5a
toll-like receptor 5b
tumor necrosis factor a (TNF superfamily, member 2)
TNF receptor-associated factor 6
peptidylprolyl isomerase A, like (cyclophilin)
acidic ribosomal protein (ARP)
RT-MLPA analysis of Mycobacterium-infected zebrafish adults
RT-MLPA analysis of Salmonella- and Mycobacterium-infected zebrafish embryos
Next we performed RT-MLPA analyses on samples from infection studies in embryos. Initial tests showed that the assay conditions developed for samples from M. marinum-infected adult fish were not applicable to samples from embryos, because several genes showed strongly different basal or induced expression levels between adult and embryonic tissues. Therefore, titration levels of competitor oligonucleotides had to be adjusted for analysis of embryo samples. The titration was performed on samples from S. typhimurium-infected embryos at 8 hpi, a stage at which many of the genes included in the RT-MLPA probe set were known to be differentially expressed [15, 16, 19]. After establishment of appropriate assay conditions, S. typhimurium-induction of a broad set of immune response genes was detected, as well as repression of the cxcr3.2 and mpx genes (Figure 2B). A clear induction of several immune response genes was also observed in subsequent RT-MLPA analysis of a sample from five-day-old larvae that had been infected three days earlier by injection of M. marinum E11 bacteria into the yolk sac (Additional file 4). Therefore, the titration conditions set-up for one-day-old S. typhimurium-infected embryos were also suitable for analysis of M. marinum infection at a later developmental stage. However, it should be noted that the analysis of other developmental stages or other infection regimes, would still require a further assessment of the normalising function of the reference genes under those conditions.
Comparison of RT-MLPA and transcriptomics data
Infection of adult fish with the M. marinum E11 strain was previously shown to lead to chronic infection with no visible disease symptoms at 6 dpi . Of all 34 immune genes included the RT-MLPA set, only one (cxcr4b) showed a significant induction (2.1-fold) in the previous microarray analysis . The induction of this gene was also above the 2-fold change threshold in the RT-MLPA analysis (2.2-fold), which additionally detected minor inductions (2.0-2.5-fold) of 6 other genes.
Infection with the M. marinum Mma20 strain was previously shown to cause acute disease symptoms at 6 dpi accompanied with high induction levels of many immune response genes . In total 22 genes from the RT-MLPA gene set showed a significant change of 2-fold or higher in the microarray analysis. Similarly, 23 genes were above the 2-fold change threshold in the RT-MLPA analysis, of which 18 overlapped with those detected by microarray. All inductions above 3-fold in the microarray analysis (17 genes) were also detected by RT-MPLA, and, vice versa, the majority of inductions above 3-fold in RT-MLPA were also significant in the microarray analysis (15 out of 18 genes). Only the inductions of sarm1 (3.1-fold) and myd88 (4.2-fold) in RT-MLPA were not significant in the microarray results, and the high induction of il8 in RT-MLPA (12.6-fold) could not be verified due to its absence on the microarray platform. Eight genes were induced above 5-fold in both microarray or RT-MLPA, with mmp9 showing the highest induction in both techniques (58-fold in microarray; 72-fold in RT-MLPA). Other genes showing above 5-fold induction with only one of the two methods (7 genes excluding il8, which is absent on the microarray) also showed clear induction in the other method (2.8-3.9-fold). The largest quantitative difference between the results of the two methods was observed for il1b, which was induced 26.6-fold in the microarray analysis and 2.8-fold in RT-MLPA.
Microarray and RT-MLPA data of S. typhimurium-infected embryos were also in good agreement, not only showing similar gene induction profiles but also consistent down-regulation (approx. 2-fold) of cxcr3.2 and mpx expression (Figure 2B, Additional file 3). In total 16 genes in the microarray analysis and 18 in RT-MLPA showed fold-change differences above 2-fold, of which 13 were overlapping between the two methods. With the exception of ccl20 (4-fold induction in microarray), all other genes (9) showing above 3-fold change in the microarray analysis were also picked up by RT-MLPA. Vice versa, with the exception of tlr5b (5-fold induction in RT-MLPA), all other genes (8) with above 3-fold change in RT-MLPA were also significant in the microarray analysis. Although the induction of tlr5b was below the 2-fold change threshold, it showed 1.7-fold induction in the microarray analysis supported by 9 probes with a significant P-value (<0.0001).
In conclusion, both for M. marinum infection of adult fish and for S. typhimurium infection of embryos the results of microarray and RT-MLPA were largely consistent in that differential expression of the majority of genes tested was confirmed by both methods. As both methods are to be considered semi-quantitative and rely on entirely different technology and data processing, it is not surprising that differences in the absolute induction levels were observed. A possible explanation for some discrepancies is that the microarray and RT-MLPA are measuring different transcripts due to alternative splicing.
Validation of RT-MLPA data by real-time PCR
In this work, we have developed an RT-MLPA analysis panel for relative quantification of innate immune gene expression in zebrafish. The method allows the rapid semi-quantitative expression screening of 34 genes involved in TLR signalling, transcriptional activation of the immune response, cytokine and chemokine production, and antimicrobial defence. Expression levels of these genes are determined relative to the expression of three reference genes in a single tube assay. The validity of the assay was demonstrated by comparison with transcriptomic data sets and real-time PCR analysis. Differential expression levels of the immune response genes detected with RT-MLPA covered a range between 2-fold and over 70-fold, similar to the results of microarray and real-time PCR analysis.
In development of the RT-MLPA assay we chose to employ a dual-colour labelling system previously used in DNA diagnostic MLPA applications . In this system, two probe sets, each in the size range of approximately 90 to 180 oligonucleotides, are amplified using FAM-labelling and TR-labelling, respectively. In this size range it is possible to compose the RT-MLPA assay exclusively from synthetic probes, thus avoiding the laborious M13 cloning procedures used previously to extend the size range of probes for (RT-)MLPA analysis [6–8]. For future development it may be possible to further increase the number of testable mRNA targets by 50% with the use of a third label, which has also been reported in DNA diagnostic MLPA . This would also facilitate further increasing the number of different reference genes in the assay.
The RT-MLPA assay was successfully applied to the analysis of RNA samples from infection experiments in adult and embryonic zebrafish. However, analysis of adult and embryonic material required different assay conditions. In RT-MLPA analysis it is necessary to compensate for large differences in expression levels of genes by the addition of competitor oligonucleotides to the probe mix . We found that the basal and infection-induced expression levels of several genes differed to such an extent between adult and embryonic tissues that titration of the probe mix with competitor oligonucleotides had to be adjusted for these different developmental stages. Fortunately, assay conditions established for one-day-old S.typhimurium-infected embryos could be transferred without further adjustment to five-day-old M. marinum-infected larvae. Thus, by employing two types of titration conditions, we have been able to establish an RT-MLPA assay for infection studies in adult zebrafish and a second RT-MLPA assay that is applicable to infection studies in both embryos and larvae and with different pathogens.
Due to the fact that RT-MLPA is a relative quantification method, the composition of the probe mix cannot be easily altered without adjustment of the assay conditions. The replacement of one probe by another, or the addition of a probe for a new target transcript, will affect the peak heights of other transcripts. Therefore, especially if the new probe results in a large peak, this may require re-titrating the probe mix, as was also necessary when the sample-type was changed from adult to embryonic zebrafish. Since re-titration of the assay is a time-consuming step, RT-MLPA analysis is most suitable for recurrent analysis of the same set of target mRNAs under comparable experimental conditions. For such medium or high throughput screening applications, the innate immune response RT-MLPA assay developed in this study provides a rapid, cheap, and robust analysis tool.
Acknowledgements and Funding
We thank Monika Hidding (BaseClear B.V.) for technical assistance, Anna Zakrzewska (Leiden University), Oliver W. Stockhammer (Leiden University), Zakia Kanwal (Leiden University), and Ralph Carvalho (ZF-Screens B.V., Leiden, The Netherlands) for RNA samples, and the staff of MRC Holland B.V. (Amsterdam, The Netherlands) for valuable advice on synthetic RT-MLPA probe design. This work was supported by the European Commission Sixth Framework Project ZF-TOOLS (LSHG-CT-2006-037220).
- Meeker ND, Trede NS: Immunology and zebrafish: spawning new models of human disease. Dev Comp Immunol. 2008, 32: 745-57.PubMedView ArticleGoogle Scholar
- Meijer AH, Spaink HP: Host-pathogen interactions made transparent with the zebrafish model. Current Drug Targets. 2011,Google Scholar
- Amsterdam A, Hopkins N: Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet. 2006, 22: 473-8. 10.1016/j.tig.2006.06.011.PubMedView ArticleGoogle Scholar
- Bowman TV, Zon LI: Swimming into the future of drug discovery: in vivo chemical screens in zebrafish. ACS Chem Biol. 2010, 5: 159-61. 10.1021/cb100029t.PubMedView ArticleGoogle Scholar
- Carvalho R, de Sonneville J, Stockhammer OW, Savage ND, Veneman W, Dirks RP, Meijer AH, Spaink HP: A high-throughput screen for tuberculosis progression. PLoS ONE. 2011, 6: e16779-10.1371/journal.pone.0016779.PubMedPubMed CentralView ArticleGoogle Scholar
- Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acid Research. 2002, 30: e57-10.1093/nar/gnf056.View ArticleGoogle Scholar
- Ohnesorg T, Turbitt E, White SJ: The many faces of MLPA. Methods Mol Biol. 2011, 687: 193-205. 10.1007/978-1-60761-944-4_13.PubMedView ArticleGoogle Scholar
- Eldering E, Spek CA, Aberson HL, Grummels A, Derks IA, de Vos AF, McElgunn CJ, Schouten JP: Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res. 2003, 31: e153-10.1093/nar/gng153.PubMedPubMed CentralView ArticleGoogle Scholar
- Spek CA, Verbon A, Aberson H, Pribble JP, McElgunn CJ, Turner T, Axtelle T, Schouten J, Van Der Poll T, Reitsma PH: Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J Clin Immunol. 2003, 23: 132-40. 10.1023/A:1022528912387.PubMedView ArticleGoogle Scholar
- Hess CJ, Denkers F, Ossenkoppele GJ, Waisfisz Q, McElgunn CJ, Eldering E, Schouten JP, Schuurhuis GJ: Gene expression profiling of minimal residual disease in acute myeloid leukaemia by novel multiplex-PCR-based method. Leukemia. 2004, 18: 1981-8. 10.1038/sj.leu.2403520.PubMedView ArticleGoogle Scholar
- Stern RF, Roberts RG, Mann K, Yau SC, Berg J, Ogilvie CM: Multiplex ligation-dependent probe amplification using a completely synthetic probe set. BioTechniques. 2004, 37: 399-405.PubMedGoogle Scholar
- White SJ, Vink GR, Kriek M, Wuyts W, Schouten J, Bakker B, Breuning MH, den Dunnen JT: Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat. 2004, 24: 86-92. 10.1002/humu.20054.PubMedView ArticleGoogle Scholar
- Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3: research0034-PubMedPubMed CentralView ArticleGoogle Scholar
- van der Sar AM, Spaink HP, Zakrzewska A, Bitter W, Meijer AH: Specificity of the zebrafish host transcriptome response to acute and chronic mycobacterial infection and the role of innate and adaptive immune components. Mol Immunol. 2009, 46: 2317-32. 10.1016/j.molimm.2009.03.024.PubMedView ArticleGoogle Scholar
- Stockhammer OW, Zakrzewska A, Hegedûs Z, Spaink HP, Meijer AH: Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection. J Immunol. 2009, 182: 5641-53. 10.4049/jimmunol.0900082.PubMedView ArticleGoogle Scholar
- Stockhammer OW, Rauwerda H, Wittink FR, Breit TM, Meijer AH, Spaink HP: Transcriptome analysis of Traf6 function in the innate immune response of zebrafish embryos. Mol Immunol. 2010, 48: 179-90. 10.1016/j.molimm.2010.08.011. Stockhammer et al, 2010PubMedView ArticleGoogle Scholar
- Meijer AH, Verbeek FJ, Salas-Vidal E, Corredor-Adamez M, Bussman J, van der Sar AM, Otto GW, Geisler R, Spaink HP: Transcriptome profiling of adult zebrafish at the late stage of chronic tuberculosis due to Mycobacterium marinum infection. Mol Immunol. 2005, 42: 1185-1203. 10.1016/j.molimm.2004.11.014.PubMedView ArticleGoogle Scholar
- Hegedűs Z, Zakrzewska A, Agoston VC, Ordas A, Rácz P, Mink M, Spaink HP, Meijer AH: Deep sequencing of the zebrafish transcriptome response to mycobacterium infection. Mol Immunol. 2009, 46: 2918-30. 10.1016/j.molimm.2009.07.002.PubMedView ArticleGoogle Scholar
- Ordas A, Hegedus Z, Henkel CV, Stockhammer OW, Butler D, Jansen HJ, Racz P, Mink M, Spaink HP, Meijer AH: Deep sequencing of the innate immune transcriptomic response of zebrafish embryos to Salmonella infection. Fish Shellfish Immunol, Special Issue of the EOFFI symposium. 2010,Google Scholar
- Harteveld CL, Voskamp A, Phylipsen M, Akkermans N, den Dunnen JT, White SJ, Giordano PC: Nine unknown rearrangements in 16p13.3 and 11p15.4 causing a- and b-thalassaemia characterised by high resolution multiplex ligation dependent probe amplification. J Med Genet. 2005, 42: 922-931. 10.1136/jmg.2005.033597.PubMedPubMed CentralView ArticleGoogle Scholar
- Nomiyama H, Hieshima K, Osada N, Kato-Unoki Y, Otsuka-Ono K, Takegawa S, Izawa T, Yoshizawa A, Kikuchi Y, Tanase S, Miura R, Kusuda J, Nakao M, Yoshie O: Extensive expansion and diversification of the chemokine gene family in zebrafish: identification of a novel chemokine subfamily CX. BMC Genomics. 2008, 9: 222-10.1186/1471-2164-9-222.PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.